id | C00003025 |
---|---|
Name | Zearalenone |
CAS RN | 17924-92-4 |
Standard InChI | InChI=1S/C18H22O5/c1-12-6-5-9-14(19)8-4-2-3-7-13-10-15(20)11-16(21)17(13)18(22)23-12/h3,7,10-12,20-21H,2,4-6,8-9H2,1H3/b7-3+/t12-/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C18H22O5/c1-12-6-5-9-14(19)8-4-2-3-7-13-10-15(20)11-16(21)17(13)18(22)23-12/h3,7,10-12,20-21H,2,4-6,8-9H2,1H3 |
Phytochemical cluster | |
---|---|
KCF-S cluster | No. 790 |
By standard InChI | CHEMBL454173 |
---|---|
By standard InChI Main Layer | CHEMBL454173 CHEMBL1330445 CHEMBL1397216 |
By LinkDB | C09981 |
---|
By CAS RN | D015025 |
---|
class name | count |
---|
family name | count |
---|---|
Nectriaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Gibberella zeae | 5518 | Nectriaceae | Fungi |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL454173 |
CHEMBL2114895
(1)
|
7 / 44 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | CHEMBL454173 |
CHEMBL1004482
(1)
|
0 / 0 |
Q14289 | Protein-tyrosine kinase 2-beta | Fak | CHEMBL1330445 |
CHEMBL1614388
(1)
|
0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL454173 CHEMBL1330445 |
CHEMBL1613842
(2)
|
4 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL454173 |
CHEMBL2114784
(1)
|
1 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL454173 |
CHEMBL1794573
(2)
|
2 / 2 |
Q15759 | Mitogen-activated protein kinase 11 | p38 | CHEMBL454173 |
CHEMBL1004486
(1)
|
0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL1330445 |
CHEMBL1614103
(1)
CHEMBL1614031
(1)
|
1 / 1 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL454173 |
CHEMBL1794524
(2)
CHEMBL1794552
(3)
|
0 / 0 |
Q9H2G2 | STE20-like serine/threonine-protein kinase | STE serine/threonine protein kinase SLK subfamily | CHEMBL454173 |
CHEMBL1004491
(1)
|
0 / 0 |
Q16659 | Mitogen-activated protein kinase 6 | CMGC serine/threonine protein kinase ERK3 subfamily | CHEMBL454173 |
CHEMBL1004485
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL1330445 |
CHEMBL1614544
(1)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL454173 |
CHEMBL1614281
(1)
CHEMBL1614361
(1)
|
3 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL454173 |
CHEMBL1794399
(1)
|
3 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | CHEMBL454173 |
CHEMBL1794471
(1)
|
0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL454173 |
CHEMBL1004481
(1)
|
0 / 0 |
O00444 | Serine/threonine-protein kinase PLK4 | PLK serine/threonine protein kinase subfamily | CHEMBL454173 |
CHEMBL1004495
(1)
|
0 / 0 |
Q9NQU5 | Serine/threonine-protein kinase PAK 6 | STE serine/threonine protein kinase PAKB subfamily | CHEMBL454173 |
CHEMBL1004496
(1)
|
0 / 0 |
O75828 | Carbonyl reductase [NADPH] 3 | Enzyme | CHEMBL454173 |
CHEMBL1004501
(1)
CHEMBL1004502
(1)
CHEMBL1004503 (1) |
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL454173 |
CHEMBL1794376
(1)
CHEMBL1794339
(1)
|
2 / 3 |
Q13188 | Serine/threonine-protein kinase 3 | STE serine/threonine protein kinase MST subfamily | CHEMBL454173 |
CHEMBL1004490
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL454173 CHEMBL1330445 CHEMBL1397216 |
CHEMBL1614458
(4)
|
0 / 0 |
P07332 | Tyrosine-protein kinase Fes/Fps | Fer | CHEMBL454173 |
CHEMBL1004488
(1)
|
0 / 0 |
P16152 | Carbonyl reductase [NADPH] 1 | Enzyme | CHEMBL454173 |
CHEMBL1004498
(1)
CHEMBL1004499
(1)
CHEMBL1004500 (1) CHEMBL1004504 (1) |
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL454173 |
CHEMBL992088
(1)
|
0 / 1 |
P10145 | Interleukin-8 | Secreted protein | CHEMBL454173 |
CHEMBL2114835
(2)
|
0 / 0 |
Q99683 | Mitogen-activated protein kinase kinase kinase 5 | Ste11 | CHEMBL454173 |
CHEMBL1004489
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL454173 |
CHEMBL1794382
(3)
CHEMBL1794456
(1)
|
0 / 1 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL454173 |
CHEMBL1794510
(1)
|
5 / 3 |
P52564 | Dual specificity mitogen-activated protein kinase kinase 6 | Ste7 | CHEMBL454173 |
CHEMBL1004493
(1)
|
0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | CHEMBL454173 |
CHEMBL1794437
(2)
|
0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL454173 |
CHEMBL1613808
(2)
|
0 / 0 |
O14976 | Cyclin-G-associated kinase | NAK serine/threonine protein kinase subfamily | CHEMBL454173 |
CHEMBL1004484
(1)
|
0 / 0 |
O94804 | Serine/threonine-protein kinase 10 | STE serine/threonine protein kinase SLK subfamily | CHEMBL454173 |
CHEMBL1004492
(1)
|
1 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL454173 |
CHEMBL1614227
(2)
|
3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL454173 CHEMBL1330445 |
CHEMBL1614038
(3)
|
2 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | CHEMBL454173 |
CHEMBL2114842
(2)
|
0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL1330445 |
CHEMBL1738588
(1)
CHEMBL1738317
(1)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL454173 |
CHEMBL1794364
(3)
CHEMBL1794542
(3)
|
1 / 1 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL454173 |
CHEMBL1614240
(1)
|
0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL454173 CHEMBL1397216 |
CHEMBL1614108
(3)
CHEMBL1613886
(3)
|
0 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL454173 |
CHEMBL2114890
(2)
|
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL454173 |
CHEMBL1794321
(1)
CHEMBL1794560
(2)
|
3 / 4 |
Q9HCP0 | Casein kinase I isoform gamma-1 | Ck1 | CHEMBL454173 |
CHEMBL1004494
(1)
|
0 / 0 |
Q86V86 | Serine/threonine-protein kinase pim-3 | Pim | CHEMBL454173 |
CHEMBL1004483
(1)
|
0 / 0 |
P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | CHEMBL1330445 |
CHEMBL1613874
(1)
|
0 / 0 |
P08238 | Heat shock protein HSP 90-beta | Other cytosolic protein | CHEMBL1330445 |
CHEMBL1613874
(1)
|
0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | CHEMBL454173 |
CHEMBL2354287
(1)
|
1 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D015025 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | ABCC1 protein results in increased transport of Zearalenone |
increases transport
|
protein |
19647055
|
D015025 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | verlukast inhibits the reaction [ABCC1 protein results in increased transport of Zearalenone] |
decreases reaction
/ increases transport |
protein |
19647055
|
D015025 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Zearalenone inhibits the reaction [ABCC1 protein results in increased transport of calcein AM] |
decreases reaction
/ increases transport |
protein |
19647055
|
D015025 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Zearalenone results in increased expression of ABCC1 protein |
increases expression
|
protein |
19580841
|
D015025 | 1244 |
ABCC2
ABC30 CMOAT DJS MRP2 cMRP |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | ABCC2 protein results in increased transport of Zearalenone |
increases transport
|
protein |
19647055
|
D015025 | 1244 |
ABCC2
ABC30 CMOAT DJS MRP2 cMRP |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | verlukast inhibits the reaction [ABCC2 protein results in increased transport of Zearalenone] |
decreases reaction
/ increases transport |
protein |
19647055
|
D015025 | 1244 |
ABCC2
ABC30 CMOAT DJS MRP2 cMRP |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Zearalenone inhibits the reaction [ABCC2 protein results in increased transport of calcein AM] |
decreases reaction
/ increases transport |
protein |
19647055
|
D015025 | 1244 |
ABCC2
ABC30 CMOAT DJS MRP2 cMRP |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Zearalenone results in increased expression of ABCC2 mRNA |
increases expression
|
mRNA |
19580841
|
D015025 | 8714 |
ABCC3
ABC31 EST90757 MLP2 MOAT-D MRP3 cMOAT2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Zearalenone inhibits the reaction [ABCC3 protein results in increased transport of calcein AM] |
decreases reaction
/ increases transport |
protein |
19647055
|
D015025 | 8714 |
ABCC3
ABC31 EST90757 MLP2 MOAT-D MRP3 cMOAT2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Zearalenone results in decreased expression of ABCC3 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 9429 |
ABCG2
ABC15 ABCP BCRP BCRP1 BMDP CD338 CDw338 EST157481 GOUT1 MRX MXR MXR1 UAQTL1 |
ATP-binding cassette, sub-family G (WHITE), member 2 | Zearalenone results in increased expression of ABCG2 mRNA |
increases expression
|
mRNA |
19580841
|
D015025 | 1238 |
ACKR2
CCBP2 CCR10 CCR9 CMKBR9 D6 hD6 |
atypical chemokine receptor 2 | Zearalenone results in decreased expression of ACKR2 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 56999 |
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Zearalenone results in increased expression of ADAMTS9 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 249 |
ALPL
AP-TNAP APTNAP HOPS TNAP TNSALP |
alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) | fulvestrant inhibits the reaction [[Zearalenone binds to ESR1 protein] which results in increased activity of ALPL protein] |
affects binding
/ decreases reaction / increases activity |
protein |
12650720
|
D015025 | 249 |
ALPL
AP-TNAP APTNAP HOPS TNAP TNSALP |
alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) | [Zearalenone binds to ESR1 protein] which results in increased activity of ALPL protein |
affects binding
/ increases activity |
protein |
12650720
|
D015025 | 251 |
ALPPL2
ALPG ALPPL GCAP |
alkaline phosphatase, placental-like 2 (EC:3.1.3.1) | Zearalenone results in increased expression of ALPPL2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 64682 |
ANAPC1
APC1 MCPR TSG24 |
anaphase promoting complex subunit 1 | Zearalenone results in increased expression of ANAPC1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 55107 |
ANO1
DOG1 ORAOV2 TAOS2 TMEM16A |
anoctamin 1, calcium activated chloride channel | Zearalenone results in increased expression of ANO1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 348 |
APOE
AD2 LDLCQ5 LPG |
apolipoprotein E | Zearalenone results in decreased expression of APOE mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 367 |
AR
AIS DHTR HUMARA HYSP1 KD NR3C4 SBMA SMAX1 TFM |
androgen receptor | Zearalenone inhibits the reaction [Metribolone results in increased activity of AR protein] |
decreases reaction
/ increases activity |
protein |
18324785
|
D015025 | 367 |
AR
AIS DHTR HUMARA HYSP1 KD NR3C4 SBMA SMAX1 TFM |
androgen receptor | Zearalenone inhibits the reaction [Testosterone binds to and results in increased activity of AR protein] |
affects binding
/ decreases reaction / increases activity |
protein |
21803136
|
D015025 | 427 |
ASAH1
AC ACDase ASAH PHP PHP32 SMAPME |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) | Zearalenone results in decreased expression of ASAH1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 80150 |
ASRGL1
ALP ALP1 CRASH |
asparaginase like 1 (EC:3.5.1.1 3.4.19.5) | Zearalenone results in increased expression of ASRGL1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 64756 |
ATPAF1
ATP11 ATP11p |
ATP synthase mitochondrial F1 complex assembly factor 1 | Zearalenone results in decreased expression of ATPAF1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | Zearalenone affects the localization of BAX protein |
affects localization
|
protein |
19541794
|
D015025 | 636 |
BICD1
BICD |
bicaudal D homolog 1 (Drosophila) | Zearalenone results in increased expression of BICD1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 662 |
BNIP1
NIP1 SEC20 TRG-8 |
BCL2/adenovirus E1B 19kDa interacting protein 1 | Zearalenone results in increased expression of BNIP1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 79680 |
C22orf29
BOP |
chromosome 22 open reading frame 29 | Zearalenone results in increased expression of C22ORF29 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 50854 |
C6orf48
D6S57 G8 |
chromosome 6 open reading frame 48 | Zearalenone results in decreased expression of C6ORF48 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 760 |
CA2
CA-II CAC CAII Car2 |
carbonic anhydrase II (EC:4.2.1.1) | Zearalenone results in increased expression of CA2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 91768 |
CABLES1
CABL1 CABLES HsT2563 IK3-1 |
Cdk5 and Abl enzyme substrate 1 | Zearalenone results in increased expression of CABLES1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 10753 |
CAPN9
GC36 nCL-4 |
calpain 9 (EC:3.4.22.-) | Zearalenone results in increased expression of CAPN9 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 833 |
CARS
CARS1 CYSRS MGC:11246 |
cysteinyl-tRNA synthetase (EC:6.1.1.16) | Zearalenone results in increased expression of CARS mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Zearalenone results in increased activity of CASP3 protein |
increases activity
|
protein |
19541794
19705349 |
D015025 | 863 |
CBFA2T3
ETO2 MTG16 MTGR2 ZMYND4 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | Zearalenone results in increased expression of CBFA2T3 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 1052 |
CEBPD
C/EBP-delta CELF CRP3 NF-IL6-beta |
CCAAT/enhancer binding protein (C/EBP), delta | Zearalenone results in increased expression of CEBPD mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 1081 |
CGA
CG-ALPHA FSHA GPHA1 GPHa HCG LHA TSHA |
glycoprotein hormones, alpha polypeptide | fulvestrant inhibits the reaction [Zearalenone results in increased expression of CGA protein] |
decreases reaction
/ increases expression |
protein |
19580841
|
D015025 | 1081 |
CGA
CG-ALPHA FSHA GPHA1 GPHa HCG LHA TSHA |
glycoprotein hormones, alpha polypeptide | Zearalenone results in increased expression of CGA protein |
increases expression
|
protein |
19580841
|
D015025 | 1082 |
CGB
CGB3 CGB5 CGB7 CGB8 hCGB |
chorionic gonadotropin, beta polypeptide | Zearalenone results in increased expression of CGB protein |
increases expression
|
protein |
22310176
|
D015025 | 494143 |
CHAC2
|
ChaC, cation transport regulator homolog 2 (E. coli) | Zearalenone results in increased expression of CHAC2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 84518 |
CNFN
PLAC8L2 |
cornifelin | Zearalenone results in decreased expression of CNFN mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 23603 |
CORO1C
HCRNN4 |
coronin, actin binding protein, 1C | Zearalenone results in increased expression of CORO1C mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 51596 |
CUTA
ACHAP C6orf82 |
cutA divalent cation tolerance homolog (E. coli) | Zearalenone results in decreased expression of CUTA mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 1523 |
CUX1
CASP CDP CDP/Cut CDP1 COY1 CUTL1 CUX Clox Cux/CDP GOLIM6 Nbla10317 p100 p110 p200 p75 |
cut-like homeobox 1 | Zearalenone results in decreased expression of CUX1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | Zearalenone affects the localization of CYCS protein |
affects localization
|
protein |
19541794
|
D015025 | 1588 |
CYP19A1
ARO ARO1 CPV1 CYAR CYP19 CYPXIX P-450AROM |
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | Zearalenone results in decreased activity of CYP19A1 protein |
decreases activity
|
protein |
16023337
|
D015025 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Tamoxifen inhibits the reaction [Zearalenone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]] |
decreases reaction
/ increases activity |
protein |
15157572
|
D015025 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Tamoxifen inhibits the reaction [Zearalenone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]] |
decreases reaction
/ increases expression |
mRNA |
15157572
|
D015025 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Zearalenone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] |
decreases reaction
/ increases activity |
protein |
15157572
|
D015025 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Zearalenone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
15157572
|
D015025 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Zearalenone results in decreased activity of CYP1A1 protein |
decreases activity
|
protein |
15157572
|
D015025 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Zearalenone results in decreased expression of CYP1A1 mRNA |
decreases expression
|
mRNA |
15157572
|
D015025 | 1544 |
CYP1A2
CP12 P3-450 P450(PA) |
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | CYP1A2 protein results in increased hydroxylation of Zearalenone |
increases hydroxylation
|
protein |
19931366
|
D015025 | 1544 |
CYP1A2
CP12 P3-450 P450(PA) |
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | [CYP1A2 protein results in increased hydroxylation of Zearalenone] which results in increased chemical synthesis of Catechols |
increases chemical synthesis
/ increases hydroxylation |
protein |
19931366
|
D015025 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | Zearalenone promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1B1 protein] |
increases activity
/ increases reaction |
protein |
15157572
|
D015025 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | Zearalenone results in increased activity of CYP1B1 protein |
increases activity
|
protein |
15157572
|
D015025 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | Zearalenone results in increased expression of CYP3A4 mRNA |
increases expression
|
mRNA |
15569515
|
D015025 | 308585 | Zearalenone results in decreased expression of DHRS10 mRNA |
decreases expression
|
mRNA |
19371625
|
||
D015025 | 9249 |
DHRS3
DD83.1 RDH17 Rsdr1 SDR1 SDR16C1 retSDR1 |
dehydrogenase/reductase (SDR family) member 3 (EC:1.1.1.300) | Zearalenone results in increased expression of DHRS3 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 55715 |
DOK4
|
docking protein 4 | Zearalenone results in increased expression of DOK4 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 1891 |
ECH1
HPXEL |
enoyl CoA hydratase 1, peroxisomal | Zearalenone results in decreased expression of ECH1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 2037 |
EPB41L2
4.1-G 4.1G |
erythrocyte membrane protein band 4.1-like 2 | Zearalenone results in increased expression of EPB41L2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 55040 |
EPN3
|
epsin 3 | Zearalenone results in decreased expression of EPN3 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 2065 |
ERBB3
ErbB-3 HER3 LCCS2 MDA-BF-1 c-erbB-3 c-erbB3 erbB3-S p180-ErbB3 p45-sErbB3 p85-sErbB3 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 (EC:2.7.10.1) | Zearalenone results in decreased expression of ERBB3 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 2071 |
ERCC3
BTF2 GTF2H RAD25 TFIIH XPB |
excision repair cross-complementing rodent repair deficiency, complementation group 3 (EC:3.6.4.12) | Zearalenone results in increased expression of ERCC3 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 121506 |
ERP27
C12orf46 PDIA8 |
endoplasmic reticulum protein 27 | Zearalenone results in decreased expression of ERP27 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 83715 |
ESPN
DFNB36 |
espin | Zearalenone results in increased expression of ESPN mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | fulvestrant inhibits the reaction [[Zearalenone binds to ESR1 protein] which results in increased activity of ALPL protein] |
affects binding
/ decreases reaction / increases activity |
protein |
12650720
|
D015025 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Zearalenone binds to and results in decreased activity of ESR1 protein |
affects binding
/ decreases activity |
protein |
15084758
|
D015025 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Zearalenone binds to and results in increased activity of ESR1 protein |
affects binding
/ increases activity |
protein |
9751507
15084758 |
D015025 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Zearalenone binds to ESR1 protein |
affects binding
|
protein |
11162928
12598185 15169976 19233257 19913605 |
D015025 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | [Zearalenone binds to ESR1 protein] which results in increased activity of ALPL protein |
affects binding
/ increases activity |
protein |
12650720
|
D015025 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Zearalenone promotes the reaction [ESR1 protein alternative form binds to ESR1 protein alternative form] |
affects binding
/ increases reaction |
protein |
19233257
|
D015025 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Zearalenone promotes the reaction [NCOA2 protein binds to ESR1 protein] |
affects binding
/ increases reaction |
protein |
15084758
|
D015025 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Zearalenone results in increased activity of ESR1 protein |
increases activity
|
protein |
11331656
|
D015025 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Zearalenone binds to and results in decreased activity of ESR2 protein |
affects binding
/ decreases activity |
protein |
15084758
|
D015025 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Zearalenone binds to and results in increased activity of ESR2 protein |
affects binding
/ increases activity |
protein |
9751507
|
D015025 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Zearalenone binds to ESR2 protein |
affects binding
|
protein |
15169976
19913605 |
D015025 | 55224 |
ETNK2
EKI2 HMFT1716 |
ethanolamine kinase 2 (EC:2.7.1.82) | Zearalenone results in increased expression of ETNK2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 11170 |
FAM107A
DRR1 TU3A |
family with sequence similarity 107, member A | Zearalenone results in decreased expression of FAM107A mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 64855 |
FAM129B
C9orf88 MEG-3 MINERVA OC58 bA356B19.6 |
family with sequence similarity 129, member B | Zearalenone results in decreased expression of FAM129B mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 252995 |
FNDC5
FRCP2 irisin |
fibronectin type III domain containing 5 | Zearalenone results in decreased expression of FNDC5 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 2348 |
FOLR1
FBP FOLR |
folate receptor 1 (adult) | Zearalenone results in decreased expression of FOLR1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 2297 |
FOXD1
FKHL8 FREAC4 |
forkhead box D1 | Zearalenone results in increased expression of FOXD1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 2302 |
FOXJ1
FKHL13 HFH-4 HFH4 |
forkhead box J1 | Zearalenone results in decreased expression of FOXJ1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 50486 |
G0S2
RP1-28O10.2 |
G0/G1switch 2 | Zearalenone results in increased expression of G0S2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 8693 |
GALNT4
GALNAC-T4 GALNACT4 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) (EC:2.4.1.41) | Zearalenone results in increased expression of GALNT4 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 8811 |
GALR2
GAL2-R GALNR2 GALR-2 |
galanin receptor 2 | Zearalenone results in decreased expression of GALR2 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 81544 |
GDPD5
GDE2 PP1665 |
glycerophosphodiester phosphodiesterase domain containing 5 | Zearalenone results in increased expression of GDPD5 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 64785 |
GINS3
PSF3 |
GINS complex subunit 3 (Psf3 homolog) | Zearalenone results in decreased expression of GINS3 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 51022 |
GLRX2
CGI-133 GRX2 |
glutaredoxin 2 | Zearalenone results in increased expression of GLRX2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 2852 |
GPER1
CEPR CMKRL2 DRY12 FEG-1 GPCR-Br GPER GPR30 LERGU LERGU2 LyGPR |
G protein-coupled estrogen receptor 1 | Zearalenone binds to GPER1 protein |
affects binding
|
protein |
17088055
|
D015025 | 350383 |
GPR142
PGR2 |
G protein-coupled receptor 142 | Zearalenone results in increased expression of GPR142 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 9687 |
GREB1
|
growth regulation by estrogen in breast cancer 1 | Zearalenone results in increased expression of GREB1 mRNA |
increases expression
|
mRNA |
19371625
22494775 |
D015025 | 79792 |
GSDMD
DF5L DFNA5L GSDMDC1 |
gasdermin D | Zearalenone results in decreased expression of GSDMD mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 145864 |
HAPLN3
EXLD1 HsT19883 |
hyaluronan and proteoglycan link protein 3 | Zearalenone results in decreased expression of HAPLN3 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 54626 |
HES2
bHLHb40 |
hes family bHLH transcription factor 2 | Zearalenone results in increased expression of HES2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 3017 |
HIST1H2BD
H2B.1B H2B/b H2BFB HIRIP2 dJ221C16.6 |
histone cluster 1, H2bd | Zearalenone results in decreased expression of HIST1H2BD mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 3096 |
HIVEP1
CIRIP CRYBP1 MBP-1 PRDII-BF1 Schnurri-1 ZAS1 ZNF40 ZNF40A |
human immunodeficiency virus type I enhancer binding protein 1 | Zearalenone results in increased expression of HIVEP1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 3151 |
HMGN2
HMG17 |
high mobility group nucleosomal binding domain 2 | Zearalenone results in decreased expression of HMGN2 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 3303 |
HSPA1A
HSP70-1 HSP70-1A HSP70I HSP72 HSPA1 |
heat shock 70kDa protein 1A | Zearalenone results in increased expression of HSPA1A mRNA |
increases expression
|
mRNA |
19051279
|
D015025 | 3303 |
HSPA1A
HSP70-1 HSP70-1A HSP70I HSP72 HSPA1 |
heat shock 70kDa protein 1A | Zearalenone results in increased expression of HSPA1A protein |
increases expression
|
protein |
19051279
|
D015025 | 3315 |
HSPB1
CMT2F HMN2B HS.76067 HSP27 HSP28 Hsp25 SRP27 |
heat shock 27kDa protein 1 | Zearalenone results in increased expression of HSPB1 protein |
increases expression
|
protein |
19051279
|
D015025 | 10410 |
IFITM3
1-8U DSPA2b IP15 |
interferon induced transmembrane protein 3 | Zearalenone results in decreased expression of IFITM3 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 3489 |
IGFBP6
IBP6 |
insulin-like growth factor binding protein 6 | Zearalenone results in decreased expression of IGFBP6 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 3566 |
IL4R
CD124 IL-4RA IL4RA |
interleukin 4 receptor | Zearalenone results in increased expression of IL4R mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 3615 |
IMPDH2
IMPD2 IMPDH-II |
IMP (inosine 5'-monophosphate) dehydrogenase 2 (EC:1.1.1.205) | Zearalenone results in increased expression of IMPDH2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 9670 |
IPO13
IMP13 KAP13 LGL2 RANBP13 |
importin 13 | Zearalenone results in increased expression of IPO13 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 3705 |
ITPK1
ITRPK1 |
inositol-tetrakisphosphate 1-kinase (EC:2.7.1.134 2.7.1.159) | Zearalenone results in increased expression of ITPK1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 3754 |
KCNF1
IK8 KCNF KV5.1 kH1 |
potassium voltage-gated channel, subfamily F, member 1 | Zearalenone results in increased expression of KCNF1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 3762 |
KCNJ5
CIR GIRK4 KATP1 KIR3.4 LQT13 |
potassium inwardly-rectifying channel, subfamily J, member 5 | Zearalenone results in increased expression of KCNJ5 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 222658 |
KCTD20
C6orf69 dJ108K11.3 |
potassium channel tetramerization domain containing 20 | Zearalenone results in increased expression of KCTD20 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 9768 |
NS5ATP9
OEATC OEATC-1 OEATC1 PAF PAF15 p15(PAF) p15/PAF p15PAF |
KIAA0101 | Zearalenone results in decreased expression of KIAA0101 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 3872 |
KRT17
K17 PC PC2 PCHC1 |
keratin 17 | Zearalenone results in decreased expression of KRT17 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 7044 |
LEFTY2
EBAF LEFTA LEFTYA TGFB4 |
left-right determination factor 2 | Zearalenone results in decreased expression of LEFTY2 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 3956 |
LGALS1
GAL1 GBP |
lectin, galactoside-binding, soluble, 1 | Zearalenone results in decreased expression of LGALS1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 64748 |
LPPR2
PRG4 |
lipid phosphate phosphatase-related protein type 2 (EC:3.1.3.4) | Zearalenone results in increased expression of LPPR2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 5603 |
MAPK13
MAPK_13 MAPK-13 PRKM13 SAPK4 p38delta |
mitogen-activated protein kinase 13 (EC:2.7.11.24) | Zearalenone results in decreased expression of MAPK13 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 4192 |
MDK
ARAP MK NEGF2 |
midkine (neurite growth-promoting factor 2) | Zearalenone results in decreased expression of MDK mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 4222 |
MEOX1
KFS2 MOX1 |
mesenchyme homeobox 1 | Zearalenone results in decreased expression of MEOX1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 4233 |
MET
AUTS9 HGFR RCCP2 c-Met |
met proto-oncogene (EC:2.7.10.1) | Zearalenone results in increased expression of MET mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 4240 |
MFGE8
BA46 EDIL1 HMFG HsT19888 MFG-E8 MFGM OAcGD3S SED1 SPAG10 hP47 |
milk fat globule-EGF factor 8 protein | Zearalenone results in decreased expression of MFGE8 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 9927 |
MFN2
CMT2A CMT2A2 CPRP1 HSG MARF |
mitofusin 2 | Zearalenone results in increased expression of MFN2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 79083 |
MLPH
SLAC2-A |
melanophilin | Zearalenone results in increased expression of MLPH mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 4477 |
MSMB
HPC13 IGBF MSP MSPB PN44 PRPS PSP PSP-94 PSP57 PSP94 |
microseminoprotein, beta- | Zearalenone results in increased expression of MSMB mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 400746 |
NCMAP
C1orf130 MP11 |
noncompact myelin associated protein | Zearalenone results in increased expression of NCMAP mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 10499 |
NCOA2
GRIP1 KAT13C NCoA-2 SRC2 TIF2 bHLHe75 |
nuclear receptor coactivator 2 | Zearalenone promotes the reaction [NCOA2 protein binds to ESR1 protein] |
affects binding
/ increases reaction |
protein |
15084758
|
D015025 | 252969 |
NEIL2
NEH2 NEI2 |
nei endonuclease VIII-like 2 (E. coli) (EC:4.2.99.18) | Zearalenone results in increased expression of NEIL2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 25791 |
NGEF
ARHGEF27 EPHEXIN |
neuronal guanine nucleotide exchange factor | Zearalenone results in decreased expression of NGEF mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 8856 |
NR1I2
BXR ONR1 PAR PAR1 PAR2 PARq PRR PXR SAR SXR |
nuclear receptor subfamily 1, group I, member 2 | Zearalenone results in increased activity of NR1I2 protein |
increases activity
|
protein |
15569515
|
D015025 | 8204 |
NRIP1
RIP140 |
nuclear receptor interacting protein 1 | Zearalenone results in increased expression of NRIP1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 4902 |
NRTN
NTN |
neurturin | Zearalenone results in increased expression of NRTN mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 10439 |
OLFM1
AMY NOE1 NOELIN1 OlfA |
olfactomedin 1 | Zearalenone results in increased expression of OLFM1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 56944 |
OLFML3
HNOEL-iso OLF44 |
olfactomedin-like 3 | Zearalenone results in increased expression of OLFML3 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 10081 |
PDCD7
ES18 HES18 |
programmed cell death 7 | Zearalenone results in increased expression of PDCD7 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 5208 |
PFKFB2
PFK-2/FBPase-2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (EC:2.7.1.105 3.1.3.46) | Zearalenone results in decreased expression of PFKFB2 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 5241 |
PGR
NR3C3 PR |
progesterone receptor | fulvestrant inhibits the reaction [Zearalenone results in increased expression of PGR protein] |
decreases reaction
/ increases expression |
protein |
21803136
|
D015025 | 5241 |
PGR
NR3C3 PR |
progesterone receptor | Zearalenone inhibits the reaction [Progesterone binds to and results in increased activity of PGR protein] |
affects binding
/ decreases reaction / increases activity |
protein |
21803136
|
D015025 | 5241 |
PGR
NR3C3 PR |
progesterone receptor | Zearalenone results in increased expression of PGR mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 5241 |
PGR
NR3C3 PR |
progesterone receptor | Zearalenone results in increased expression of PGR protein |
increases expression
|
protein |
21803136
|
D015025 | 51131 |
PHF11
APY BCAP IGEL IGER IGHER NY-REN-34 NYREN34 |
PHD finger protein 11 | Zearalenone results in decreased expression of PHF11 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 5292 |
PIM1
PIM |
pim-1 oncogene (EC:2.7.11.1) | Zearalenone results in increased expression of PIM1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 23236 |
PLCB1
EIEE12 PI-PLC PLC-154 PLC-I PLC154 PLCB1A PLCB1B |
phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) | Zearalenone results in increased expression of PLCB1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 84898 |
PLXDC2
TEM7R |
plexin domain containing 2 | Zearalenone results in increased expression of PLXDC2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 5432 |
POLR2C
RPB3 RPB31 hRPB33 hsRPB3 |
polymerase (RNA) II (DNA directed) polypeptide C, 33kDa (EC:2.7.7.6) | Zearalenone results in increased expression of POLR2C mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 63978 |
PRDM14
PFM11 |
PR domain containing 14 | Zearalenone results in increased expression of PRDM14 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 5576 |
PRKAR2A
PKR2 PRKAR2 |
protein kinase, cAMP-dependent, regulatory, type II, alpha (EC:2.7.11.1) | Zearalenone results in increased expression of PRKAR2A mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 11098 |
PRSS23
SIG13 SPUVE ZSIG13 |
protease, serine, 23 | Zearalenone results in increased expression of PRSS23 mRNA |
increases expression
|
mRNA |
22494775
|
D015025 | 55647 |
RAB20
|
RAB20, member RAS oncogene family | Zearalenone results in decreased expression of RAB20 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 31818 | Zearalenone results in increased expression of RBM13 mRNA |
increases expression
|
mRNA |
19371625
|
||
D015025 | 221662 |
RBM24
RNPC6 dJ259A10.1 |
RNA binding motif protein 24 | Zearalenone results in increased expression of RBM24 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 5947 |
RBP1
CRABP-I CRBP CRBP1 CRBPI RBPC |
retinol binding protein 1, cellular | Zearalenone results in decreased expression of RBP1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 26150 |
RIBC2
C22orf11 |
RIB43A domain with coiled-coils 2 | Zearalenone results in decreased expression of RIBC2 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 116028 |
RMI2
BLAP18 C16orf75 |
RecQ mediated genome instability 2 | Zearalenone results in decreased expression of RMI2 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 10325 |
RRAGB
RAGB bA465E19.1 |
Ras-related GTP binding B | Zearalenone results in decreased expression of RRAGB mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 1903 |
S1PR3
EDG-3 EDG3 LPB3 S1P3 |
sphingosine-1-phosphate receptor 3 | Zearalenone results in increased expression of S1PR3 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 45384 | Zearalenone results in decreased expression of SAT mRNA |
decreases expression
|
mRNA |
19371625
|
||
D015025 | 54581 |
SCAND2P
SCAND2 |
SCAN domain containing 2 pseudogene | Zearalenone results in increased expression of SCAND2P mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 83443 |
SF3B5
SF3b10 Ysf3 |
splicing factor 3b, subunit 5, 10kDa | Zearalenone results in increased expression of SF3B5 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 6477 |
SIAH1
SIAH1A |
siah E3 ubiquitin protein ligase 1 (EC:6.3.2.-) | Zearalenone results in decreased expression of SIAH1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 6510 |
SLC1A5
AAAT ASCT2 ATBO M7V1 M7VS1 R16 RDRC |
solute carrier family 1 (neutral amino acid transporter), member 5 | Zearalenone results in increased expression of SLC1A5 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 1317 |
SLC31A1
COPT1 CTR1 |
solute carrier family 31 (copper transporter), member 1 | Zearalenone results in increased expression of SLC31A1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 6520 |
SLC3A2
4F2 4F2HC 4T2HC CD98 CD98HC MDU1 NACAE |
solute carrier family 3 (amino acid transporter heavy chain), member 2 | Zearalenone results in increased expression of SLC3A2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 54946 |
SLC41A3
SLC41A1-L2 |
solute carrier family 41, member 3 | Zearalenone results in decreased expression of SLC41A3 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 6533 |
SLC6A6
TAUT |
solute carrier family 6 (neurotransmitter transporter), member 6 | Zearalenone results in increased expression of SLC6A6 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 8140 |
SLC7A5
4F2LC CD98 D16S469E E16 LAT1 MPE16 hLAT1 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 | Zearalenone results in increased expression of SLC7A5 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 90864 |
SPSB3
C16orf31 SSB3 |
splA/ryanodine receptor domain and SOCS box containing 3 | Zearalenone results in decreased expression of SPSB3 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 6713 |
SQLE
|
squalene epoxidase (EC:1.14.13.132) | Zearalenone results in decreased expression of SQLE mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 136853 |
SRCRB4D
S4D-SRCRB SRCRB-S4D SSC4D |
scavenger receptor cysteine rich domain containing, group B (4 domains) | Zearalenone results in decreased expression of SRCRB4D mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 6783 |
SULT1E1
EST EST-1 ST1E1 STE |
sulfotransferase family 1E, estrogen-preferring, member 1 (EC:2.8.2.4) | Zearalenone results in decreased activity of SULT1E1 protein |
decreases activity
|
protein |
16914110
|
D015025 | 7039 |
TGFA
TFGA |
transforming growth factor, alpha | Zearalenone results in increased expression of TGFA mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 7057 |
THBS1
THBS THBS-1 TSP TSP-1 TSP1 |
thrombospondin 1 | Zearalenone results in increased expression of THBS1 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 26277 |
TINF2
DKCA3 TIN2 |
TERF1 (TRF1)-interacting nuclear factor 2 | Zearalenone results in decreased expression of TINF2 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 80757 |
TMEM121
hole |
transmembrane protein 121 | Zearalenone results in decreased expression of TMEM121 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 113452 |
TMEM54
BCLP CAC-1 CAC1 |
transmembrane protein 54 | Zearalenone results in decreased expression of TMEM54 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 8718 |
TNFRSF25
APO-3 DDR3 DR3 LARD TNFRSF12 TR3 TRAMP WSL-1 WSL-LR |
tumor necrosis factor receptor superfamily, member 25 | Zearalenone results in decreased expression of TNFRSF25 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 7138 |
TNNT1
ANM NEM5 STNT TNT TNTS |
troponin T type 1 (skeletal, slow) | Zearalenone results in decreased expression of TNNT1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 8848 |
TSC22D1
Ptg-2 TGFB1I4 TSC22 |
TSC22 domain family, member 1 | Zearalenone results in decreased expression of TSC22D1 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 25987 |
TSKU
E2IG4 LRRC54 TSK |
tsukushi, small leucine rich proteoglycan | Zearalenone results in increased expression of TSKU mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 83882 |
TSPAN10
OCSP |
tetraspanin 10 | Zearalenone results in decreased expression of TSPAN10 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 23554 |
TSPAN12
EVR5 NET-2 NET2 TM4SF12 |
tetraspanin 12 | Zearalenone results in decreased expression of TSPAN12 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 54658 |
UGT1A1
BILIQTL1 GNT1 HUG-BR1 UDPGT UDPGT_1-1 UGT1 UGT1A |
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | UGT1A1 protein results in increased glucuronidation of Zearalenone |
increases glucuronidation
|
protein |
14557274
|
D015025 | 54575 |
UGT1A10
UDPGT UGT-1J UGT1-10 UGT1.10 UGT1J |
UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) | UGT1A10 protein results in increased glucuronidation of Zearalenone |
increases glucuronidation
|
protein |
14557274
|
D015025 | 54577 |
UGT1A7
UDPGT UDPGT_1-7 UGT-1G UGT1-07 UGT1.7 UGT1G |
UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) | UGT1A7 protein results in increased glucuronidation of Zearalenone |
increases glucuronidation
|
protein |
14557274
|
D015025 | 54576 |
UGT1A8
UDPGT UDPGT_1-8 UGT-1H UGT1-08 UGT1.8 UGT1A8S UGT1H |
UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) | UGT1A8 protein results in increased glucuronidation of Zearalenone |
increases glucuronidation
|
protein |
14557274
|
D015025 | 54600 |
UGT1A9
HLUGP4 LUGP4 UDPGT UDPGT_1-9 UGT-1I UGT1-09 UGT1-9 UGT1.9 UGT1AI UGT1I |
UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) | UGT1A9 protein results in increased glucuronidation of Zearalenone |
increases glucuronidation
|
protein |
14557274
|
D015025 | 84135 |
UTP15
NET21 |
UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae) | Zearalenone results in increased expression of UTP15 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 79609 |
VCPKMT
C14orf138 METTL21D VCP-KMT |
valosin containing protein lysine (K) methyltransferase | Zearalenone results in decreased expression of VCPKMT mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 7476 |
WNT7A
|
wingless-type MMTV integration site family, member 7A | Zearalenone results in decreased expression of WNT7A mRNA |
decreases expression
|
mRNA |
16534752
|
D015025 | 11060 |
WWP2
AIP2 WWp2-like |
WW domain containing E3 ubiquitin protein ligase 2 | Zearalenone results in decreased expression of WWP2 mRNA |
decreases expression
|
mRNA |
19371625
|
D015025 | 342357 |
ZKSCAN2
ZNF694 ZSCAN31 ZSCAN34 |
zinc finger with KRAB and SCAN domains 2 | Zearalenone results in increased expression of ZKSCAN2 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 9203 |
ZMYM3
DXS6673E MYM XFIM ZNF198L2 ZNF261 |
zinc finger, MYM-type 3 | Zearalenone results in increased expression of ZMYM3 mRNA |
increases expression
|
mRNA |
19371625
|
D015025 | 51364 |
ZMYND10
BLU FLU |
zinc finger, MYND-type containing 10 | Zearalenone results in decreased expression of ZMYND10 mRNA |
decreases expression
|
mRNA |
19371625
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
%606641 | Body mass index; bmi |
P37231
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#232300 | Glycogen storage disease ii |
P10253
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#601665 | Obesity |
P37231
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#273300 | Testicular germ cell tumor; tgct |
O94804
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | disease name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
Q13148
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D052776 | D015025 | Female Urogenital Diseases |
marker/mechanism
|
22310176
|
|
D009336 | D015025 | Necrosis |
marker/mechanism
|
21767629
|
|
D011248 | D015025 | Pregnancy Complications |
marker/mechanism
|
23291560
|
|
D011297 | D015025 | Prenatal Exposure Delayed Effects |
marker/mechanism
|
22310176
|
|
D011629 | D015025 | Puberty, Precocious |
marker/mechanism
|
23291560
|